ORB-0003

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameORB-0003
Drug Alias Nameanti-AXL mAb (Oribase/INSERM)OB-0003ORY-020ORB-0003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAXL receptor tyrosine kinase inhibitorsAnticancer protein kinase inhibitors
TargetsAXL receptor tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOriBase Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut National De La Sante Et De La Recherche MedicaleOriBase Pharma
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A